MicroRNA-145 targets YES and STAT1 in colon cancer cells

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

MicroRNA-145 targets YES and STAT1 in colon cancer cells. / Gregersen, Lea H; Jacobsen, Anders B; Frankel, Lisa; Wen, Jiayu; Krogh, Anders; Lund, Anders H.

In: PLoS ONE, Vol. 5, No. 1, 2010, p. e8836.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Gregersen, LH, Jacobsen, AB, Frankel, L, Wen, J, Krogh, A & Lund, AH 2010, 'MicroRNA-145 targets YES and STAT1 in colon cancer cells', PLoS ONE, vol. 5, no. 1, pp. e8836. https://doi.org/10.1371/journal.pone.0008836

APA

Gregersen, L. H., Jacobsen, A. B., Frankel, L., Wen, J., Krogh, A., & Lund, A. H. (2010). MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS ONE, 5(1), e8836. https://doi.org/10.1371/journal.pone.0008836

Vancouver

Gregersen LH, Jacobsen AB, Frankel L, Wen J, Krogh A, Lund AH. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS ONE. 2010;5(1):e8836. https://doi.org/10.1371/journal.pone.0008836

Author

Gregersen, Lea H ; Jacobsen, Anders B ; Frankel, Lisa ; Wen, Jiayu ; Krogh, Anders ; Lund, Anders H. / MicroRNA-145 targets YES and STAT1 in colon cancer cells. In: PLoS ONE. 2010 ; Vol. 5, No. 1. pp. e8836.

Bibtex

@article{72a144a01af711df8ed1000ea68e967b,
title = "MicroRNA-145 targets YES and STAT1 in colon cancer cells",
abstract = "BACKGROUND: MicroRNAs (miRNAs) have emerged as important gene regulators and are recognized as key players in tumorigenesis. miR-145 is reported to be down-regulated in several cancers, but knowledge of its targets in colon cancer remains limited. METHODOLOGY/PRINCIPAL FINDINGS: To investigate the role of miR-145 in colon cancer, we have employed a microarray based approach to identify miR-145 targets. Based on seed site enrichment analyses and unbiased word analyses, we found a significant enrichment of miRNA binding sites in the 3'-untranslated regions (UTRs) of transcripts down-regulated upon miRNA overexpression. Gene Ontology analysis showed an overrepresentation of genes involved in cell death, cellular growth and proliferation, cell cycle, gene expression and cancer. A number of the identified miRNA targets have previously been implicated in cancer, including YES, FSCN1, ADAM17, BIRC2, VANGL1 as well as the transcription factor STAT1. Both YES and STAT1 were verified as direct miR-145 targets. CONCLUSIONS/SIGNIFICANCE: The study identifies and validates new cancer-relevant direct targets of miR-145 in colon cancer cells and hereby adds important mechanistic understanding of the tumor-suppressive functions of miR-145.",
author = "Gregersen, {Lea H} and Jacobsen, {Anders B} and Lisa Frankel and Jiayu Wen and Anders Krogh and Lund, {Anders H.}",
note = "KeyWords Plus: COLORECTAL-CANCER; SUPPRESSIVE MICRORNAS; PROSTATE-CANCER; MESSENGER-RNAS; EXPRESSION; GROWTH; CARCINOMA; SIGNATURES; MECHANISM; MIR-145",
year = "2010",
doi = "10.1371/journal.pone.0008836",
language = "English",
volume = "5",
pages = "e8836",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

RIS

TY - JOUR

T1 - MicroRNA-145 targets YES and STAT1 in colon cancer cells

AU - Gregersen, Lea H

AU - Jacobsen, Anders B

AU - Frankel, Lisa

AU - Wen, Jiayu

AU - Krogh, Anders

AU - Lund, Anders H.

N1 - KeyWords Plus: COLORECTAL-CANCER; SUPPRESSIVE MICRORNAS; PROSTATE-CANCER; MESSENGER-RNAS; EXPRESSION; GROWTH; CARCINOMA; SIGNATURES; MECHANISM; MIR-145

PY - 2010

Y1 - 2010

N2 - BACKGROUND: MicroRNAs (miRNAs) have emerged as important gene regulators and are recognized as key players in tumorigenesis. miR-145 is reported to be down-regulated in several cancers, but knowledge of its targets in colon cancer remains limited. METHODOLOGY/PRINCIPAL FINDINGS: To investigate the role of miR-145 in colon cancer, we have employed a microarray based approach to identify miR-145 targets. Based on seed site enrichment analyses and unbiased word analyses, we found a significant enrichment of miRNA binding sites in the 3'-untranslated regions (UTRs) of transcripts down-regulated upon miRNA overexpression. Gene Ontology analysis showed an overrepresentation of genes involved in cell death, cellular growth and proliferation, cell cycle, gene expression and cancer. A number of the identified miRNA targets have previously been implicated in cancer, including YES, FSCN1, ADAM17, BIRC2, VANGL1 as well as the transcription factor STAT1. Both YES and STAT1 were verified as direct miR-145 targets. CONCLUSIONS/SIGNIFICANCE: The study identifies and validates new cancer-relevant direct targets of miR-145 in colon cancer cells and hereby adds important mechanistic understanding of the tumor-suppressive functions of miR-145.

AB - BACKGROUND: MicroRNAs (miRNAs) have emerged as important gene regulators and are recognized as key players in tumorigenesis. miR-145 is reported to be down-regulated in several cancers, but knowledge of its targets in colon cancer remains limited. METHODOLOGY/PRINCIPAL FINDINGS: To investigate the role of miR-145 in colon cancer, we have employed a microarray based approach to identify miR-145 targets. Based on seed site enrichment analyses and unbiased word analyses, we found a significant enrichment of miRNA binding sites in the 3'-untranslated regions (UTRs) of transcripts down-regulated upon miRNA overexpression. Gene Ontology analysis showed an overrepresentation of genes involved in cell death, cellular growth and proliferation, cell cycle, gene expression and cancer. A number of the identified miRNA targets have previously been implicated in cancer, including YES, FSCN1, ADAM17, BIRC2, VANGL1 as well as the transcription factor STAT1. Both YES and STAT1 were verified as direct miR-145 targets. CONCLUSIONS/SIGNIFICANCE: The study identifies and validates new cancer-relevant direct targets of miR-145 in colon cancer cells and hereby adds important mechanistic understanding of the tumor-suppressive functions of miR-145.

U2 - 10.1371/journal.pone.0008836

DO - 10.1371/journal.pone.0008836

M3 - Journal article

C2 - 20098684

VL - 5

SP - e8836

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 1

ER -

ID: 18044644